Monitor for actual sale execution via subsequent Form 4 filings. The filing by a major pre-IPO venture investor signals potential distribution, which could pressure the stock if the sale completes. Watch for any additional insider selling patterns in the coming weeks.
Price Chart
Executive Summary
Qiming Venture Partners VIII-HC, L.P., a venture capital affiliate of Alamar Biosciences, has filed a Form 144 notice to sell up to 435,468 shares of common stock, with an estimated aggregate market value of approximately $10.24 million based on a filing date of October 14, 2026. This represents a material insider sale intent by a significant pre-IPO investor, though the actual sale may not occur.
Key Facts
- Qiming Venture Partners VIII-HC, L.P. filed Form 144 to sell 435,468 shares of Alamar Biosciences common stock.
- Estimated aggregate market value of the proposed sale is approximately $10.24 million.
- Shares were acquired via conversion of Series C preferred shares upon the company's IPO on February 21, 2024.
- The filing date is October 14, 2026, and the sale is intended to occur on or after that date.
- The selling entity is an affiliate of the issuer, not an officer or director.
Financial Impact
Proposed sale of 435,468 shares valued at approximately $10.24 million, representing a meaningful portion of the venture fund's holdings.
Risk Factors
- The proposed sale may not be completed; Form 144 is an intent notice, not a guarantee of sale.
- If executed, the sale could signal reduced conviction from a key institutional holder, potentially weighing on sentiment.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001231919-26-001458 |
| Document: 0001231919-26-001458-index.html | 0001231919-26-001458 |
| Document: 0001231919-26-001458.txt | 0001231919-26-001458 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $31.11 (−13.46%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $31.11 (−13.46%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $31.11 (+13.46%) |
Oct 5, 2026 21d ago | Press Release | $32.26 | awaiting T+60 | — | $31.11 (−3.56%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $31.11 (−5.15%) |
Sep 1, 2026 7w ago | 8-K | $30.49 | awaiting T+60 | — | $31.11 (+2.03%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $31.11 (−14.93%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $31.11 (+13.54%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $31.11 (+9.47%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $31.11 (+29.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers